In vitro evaluation shows pomegranate extract-loaded microparticles inhibit Staphylococcus aureus without cytotoxicity, indicating their potential as safe oral antimicrobial carriers.
Antimicrobial-resistant microorganisms are a pressing public health issue, particularly relevant to One Health studies. This research investigates the antimicrobial potential of a bio-input derived from pomegranate peels, incorporated into microparticles (MPs) of pectin and retrograded starch for oral administration to treat Staphylococcus aureus infections. The MPs were analysed for bioactive compounds, in vitro antimicrobial activity, cytotoxicity, morphology, swelling, and erosion rates. Ellagic acid and punicalagins were identified in dry crude pomegranate peel extract (DCPPE) and MPs by HPLC. Solutions from MPs immersed in saline buffer (pH 7.4) for 24 h exhibited antimicrobial activity against S. aureus (>16 mg/mL). The cell viability assay showed an IC50 value over 1600 mg/mL, indicating no cytotoxicity. MPs had a spherical morphology with a circularity index of 0.900 ± 0.062 and an average diameter of 1270 mm ± 254.97. The results suggest that MPs are viable for oral DCPPE administration.
No takes yet. Share an insight, caveat, or question.
Saleme et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: